GleanMark

IKSUDA Trademark

IKSUDA is a USPTO trademark filed by IKSUDA THERAPEUTICS LIMITED. Status: Registered.

Trademark Facts

MarkIKSUDA
Serial Number79240120
Registration Number5766418
StatusRegistered
Filing Date2018-05-17
Registration Date2019-06-04
Mark TypeWord
Nice Classes001 (Chemicals), 005 (Pharmaceuticals), 016 (Paper Goods), 042 (Software & IT)
OwnerIKSUDA THERAPEUTICS LIMITED
Attorney of RecordWilliam S. Fultz
Prosecution Events36
Latest EventNA71 on 2025-10-08

Goods & Services

Pharmaceuticals for the treatment of cancer; pharmaceuticals and medical preparations for the treatment of inflammatory diseases; vaccines for the treatment of cancer; vaccines for the treatment of gene and cell therapy; vaccines for the treatment of inflammatory diseases; pharmaceutical and medical preparations for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical products for the prevention and treatment of cancer; biopharmaceuticals for the treatment of cancer; biopharmaceuticals for the treatment of inflammatory diseases; hormones and analogues for medical purposes; biopharmaceutical and pharmaceutical gene and cell therapy products, namely, therapeutic pharmaceuticals for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; Paper; cardboard; printed matter, namely, paper signs, books, manuals, business cards, newsletters, informational cards, posters, brochures, letters, certificates in the field of biotherapeutics; bookbinding material; photographs; stationery; printed instructional, educational, and teaching materials in the field of medicine; publications, namely, books, hand-outs, workbooks, posters, research articles in the fields of science, medicine and biotherapeutics; publications for the medical profession, namely, magazines, newsletters, research articles in the field of medicine; Chemical products for use in industry and science; reagents for use in scientific apparatus for chemical or biological analysis; reagents for medical research; antibody reagents for scientific purposes; in-vivo diagnostic reagents for scientific or research use; chemical preparations for scientific and industrial processes, namely, vinyl pyridine-based linkers, vinyl pyridine derivatives, and difluorosialic acid; enzymes for industrial use; cell culture media for use in scientific research; active chemical ingredients for use in the manufacture of anti-cancer drugs; Scientific and technological services, namely, scientific research, design, analysis and testing in the field of biotherapeutics for treating cancer; medical and pharmaceutical research services; research and development of vaccines and medicines; industrial analysis and research services, namely, synthetic chemistry, bioconjugation, and scientific analysis of antibody-drug conjugates and biotherapeutics; scientific research; pharmaceutical research; biological research; biotechnology testing services, namely, synthetic chemistry, recombinant protein production, bioconjugation, testing, analysis, and evaluation of antibody-drug conjugates and biotherapeutics to assure compliance with industry standards; medical research services in the field of cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting clinical trials for others; design of clinical trials for others in the field of vaccines and gene therapy; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; information, advisory and consultancy services relating to the aforesaid

Related